🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 325mg
Pepsin
59 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Silica Vegetable Cellulose natural Peppermint flavor

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement for adults, take one (1) tablet up to three times daily, preferably after each meal, or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

DO NOT USE IF OUTER BOTTLE SEAL IS MISSING, TORN OR DAMAGED IN ANY WAY.

If you are pregnant, nursing, taking any medication or have a medical condition, please consult your healthcare practitioner before taking any dietary supplement.

Keep out of reach of children.

CAUTION: Do not take in cases of stomach or duodenal pain or history of ulcers.

Contains milk.

🧪 Formulation Notes

Provides a dietarily insignificant amount of sugar.

Solgar’s Beta-Pepsin Tablets supply betaine hydrochloride, which further aids digestion by providing a favorable digestive environment.*

Solgar’s Beta-Pepsin Tablets are free of yeast, wheat, soy and gluten and are formulated without the use of artificial preservatives, flavors or colors.

BETAINE HYDROCHLORIDE WITH PEPSIN

SUGAR, SALT AND STARCH FREE

Contains milk.

Additional Information

To assure freshness and potency, store at room temperature 59(0)-86(0)F (15(0)-30(0)C). Store away from heat, light and moisture.

00240US06PD

Since 1947

Product Details

UPC / SKU 0 33984 00240 1
DSLD Entry Date 2015-04-24
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
Brand Solgar
DSLD ID 44288
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →